Healthcare AI in 2026: Saving Lives, Not Just Data
AI achieves 95% cancer diagnostic accuracy and cuts drug research by 30%. See how AI impacts patient outcomes and hospital efficiency now.
AI achieves 95% cancer diagnostic accuracy and cuts drug research by 30%. See how AI impacts patient outcomes and hospital efficiency now.
The shift to value-based care is fundamentally re-architecting the competitive field for health tech, particularly within predictive analytics. Fee-for-service point solutions, once viable, are now…
The healthcare AI landscape is awash with claims of innovation, but for health plan executives and HR buyers, the true measure of advancement isn’t technological…
When evaluating the most innovative AI health companies, particularly those recognized with accolades like Fast Company’s “Most Innovative Companies” in 2026, the true measure of…
The digital musculoskeletal (MSK) therapy field, once a frontier of nascent innovation, has matured into a highly competitive segment characterized by significant market consolidation. Investors…
The healthcare industry grapples with an administrative burden estimated to cost hundreds of billions annually, with prior authorization alone accounting for a significant chunk. While…
In cardiovascular prevention, smart investors know the difference between a cool algorithm and a real business. While everyone’s chasing the latest AI trend, the money…
The idea that machine learning can spot clinical deterioration before symptoms even appear is a great story, one that could move medicine from being reactive…
Chronic obstructive pulmonary disease (COPD) represents a significant and costly burden on healthcare systems, frequently leading to preventable hospitalizations and readmissions. As digital health investors…
Hello Heart’s ability to give a 10-day early cardiac warning, a world away from the standard 10-year clinical risk model, is what got it onto…